The Nonlinear Association Between Triglyceride Glucose-body Mass Index and Femoral Neck BMD in Nondiabetic Elderly Men: NHANES 2005-March 2020
Overview
Affiliations
Background: The triglyceride glucose-body mass index (TyG-BMI) has been considered a surrogate marker for assessing insulin resistance. We aimed to correlate the TyG-BMI, triglyceride glucose combined with body mass index, with femoral neck bone mineral density (FN BMD) in non-diabetic elderly men.
Methods: Using data from the National Health and Nutrition Examination Survey (NHANES) database, totally, 1182 eligible men aged ≥ 50 years without diabetes were included in the current study. Smoothed curves were obtained by a two-piecewise linear regression model and the threshold effects were explored by using a smoothing function.
Results: TyG-BMI was positive related with and FN BMD with or without adjustment for confounders. However, no typical dose-dependent positive association between TyG-BMI and FN BMD was observed across the TyG-BMI tertiles, indicating a non-linear association. Further analysis by the weighted two-piecewise linear regression model and recursive algorithm suggested that per SD increase in TyG-BMI increased FN BMD by 0.266 gm/cm2 when TyG-BMI lower than 168.20. However, when TyG-BMI is higher than 168.20, FN BMD only increased 0.046 gm/cm2 for per SD increase of TyG-BMI after fully adjustment (OR = 11.258, 95%CI: 6.034, 16.481). Moreover, subgroup analyses showed that higher TyG-BMI levels were related to elevated FN BMD in all groups, suggesting the consistency of the positive association within these stratas.
Conclusions: This study demonstrated that TyG-BMI is positively associated with FN BMD in a nonlinear fashion among elderly men without diabetes, which may be a reliable marker for the early identification of individuals with lower FN BMD.
Insulin Resistance and Bone Mineral Density: A Comprehensive Examination Using UK Biobank Data.
Hung Y, Yu T, Alizargar J Healthcare (Basel). 2025; 12(24.
PMID: 39765929 PMC: 11727659. DOI: 10.3390/healthcare12242502.
Shirinezhad A, Azarboo A, Ghaseminejad-Raeini A, Kanaani Nejad F, Zareshahi N, Amiri S Front Endocrinol (Lausanne). 2025; 15:1499479.
PMID: 39744182 PMC: 11688183. DOI: 10.3389/fendo.2024.1499479.
Tao J, Li H, Wang H, Tan J, Yang X Osteoporos Int. 2024; 35(12):2087-2098.
PMID: 39136721 DOI: 10.1007/s00198-024-07217-y.
Tian C, Liu J, Ma M, Wang S, Zhang Y, Feng Z Arch Osteoporos. 2024; 19(1):42.
PMID: 38796579 DOI: 10.1007/s11657-024-01395-2.